Doctor profile · Federal record
Dr. Mark Granada, M.D.
Internal Medicine Physician (CMS: Pulmonary Disease) · Annandale, VA
- NPI 1467642504
- Accepts Medicare
- MIPS 14.6 / 100 · 2023
- 23 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3289 Woodburn RD Ste 350
Annandale, VA 220037357
(703) 641-8616
Credentials & registration
- NPI registered
- July 2007 — 19 yrs on file
- Profile last updated
- February 25, 2011
- Year of graduation
- 2003 — 23 yrs since
- Specialty taxonomy
- 207R00000X — NUCC code
- State license (1)
- Massachusetts #232993
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1467642504. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,798
Distinct HCPCS
10
Medicare allowed
$423,268
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0517 |
Injection, benralizumab, 1 mg | 960 | 13 | $166 | |
94010 |
Test to measure expiratory airflow and volume | 712 | 384 | $32 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 409 | 261 | $144 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 331 | 218 | $201 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 199 | 128 | $87 | |
96372 |
Injection of drug or substance under skin or into muscle | 140 | 27 | $16 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 126 | 87 | $132 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 106 | 102 | $190 | |
95012 |
Test to measure the level of nitric oxide gas | 99 | 86 | $23 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 84 | 84 | $246 |
In context: peer comparison
Among 9 peers in Annandale Internal Medicine Physician, average services per provider: 235. This provider delivers 16× the peer median.Open Payments
Industry payments received
All-time total
$711
Transactions
19
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Inari Medical, INC. | 2 | $313.10 | |
| Amgen INC. | 4 | $92.74 | |
| AstraZeneca Pharmaceuticals Lp | 4 | $89.48 | |
| GlaxoSmithKline, LLC. | 3 | $67.53 | |
| Genzyme Corporation | 2 | $56.58 | |
| Regeneron Healthcare Solutions, INC. | 1 | $29.71 | |
| Pulmonx Corporation | 1 | $26.68 | |
| Electromed, INC. | 1 | $18.81 | |
| Novartis Pharmaceuticals Corporation | 1 | $15.87 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,747
Patients
661
Total drug cost
$422,406
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Montelukast Sodium | Generic | 468 | 155 | $8,171 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 184 | 82 | $8,124 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 177 | 38 | $167,313 |
| Prednisone | Generic | 174 | 94 | $645 |
| Fluticasone Propionate | Generic | 144 | 62 | $2,799 |
| Azelastine Hcl | Generic | 93 | 41 | $4,501 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 90 | 22 | $71,123 |
| Levocetirizine Dihydrochloride | Generic | 74 | 23 | $2,152 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 62 | 23 | $45,440 |
| Amoxicillin-Clavulanate Potass (Amoxicillin/Potassium Clav) | Brand | 58 | 27 | $692 |
Hospital affiliations
Frequently asked questions
What is Dr. Mark Granada's medical specialty?
Dr. Mark Granada practices Internal Medicine Physician in Annandale, VA.
Where does Dr. Mark Granada practice?
Dr. Mark Granada practices at 3289 Woodburn RD Ste 350, Annandale, VA 220037357. Office phone: 7036418616.
What is Dr. Mark Granada's NPI?
Dr. Mark Granada's National Provider Identifier (NPI) is 1467642504, issued by NPPES.
Does Dr. Mark Granada accept Medicare assignment?
Yes. Dr. Mark Granada accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Granada commonly perform?
Top Medicare-reported procedures in 2023: Injection, benralizumab, 1 mg (HCPCS J0517); Test to measure expiratory airflow and volume (HCPCS 94010); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.